Research interest in PGC-1α and its correlation with MetS is substantially growing since PGC-1α can be a potential therapeutic target against MetS [114,115] as it connects mitochondrial metabolism with redox homeostasis that is found to be dysfunctional in metabolic diseases. This evidence concerns the gene PPARGC1A and metabolic syndrome.